Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders

Details for Australian Patent Application No. 2003213660 (hide)

Owner Onconova Therapeutics, Inc. Temple University of the Commonwealth System of Higher Education

Inventors Reddy, Ramana M V; Reddy, Premkumar E; Bell, Stanley C

Agent Mallesons

Pub. Number AU-B-2003213660

PCT Number PCT/US03/06357

PCT Pub. Number WO2003/072062

Priority 60//360,697 28.02.02 US

Filing date 28 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 22 April 2010

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/14 (2006.01) - Quaternary ammonium compounds, e.g. edrophonium, choline

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/19 (2006.01)

A61K 31/195 (2006.01)

A61K 31/198 (2006.01)

A61K 31/4425 (2006.01) - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/661 (2006.01) - Phosphorus acids or esters thereof not having PC bonds, e.g. fosfosal, dichlorvos, malathion

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/12 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07C 311/28 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 315/04 (2006.01) Preparation of sulfones

C07C 317/28 (2006.01) Sulfones

C07D 213/20 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60//360,697 28.02.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213660

23 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213660

22 April 2010 Application Accepted

  Published as AU-B-2003213660

8 July 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 28 May 2010. Address for service in Australia - Mallesons Stephen Jaques Level 50 Bourke Place 600 Bourke Street Melbourne VIC 3000

28 October 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 May 2010

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213661-AMINO-SUBSTITUTED SULFONANILIDES AND DERIVATIVES THEREOF FOR TREATING PROLIFERATIVE DISORDERS

2003213659-MEDICAL CLIP APPLIER SAFETY ARRANGEMENT